Central nervous system (CNS) neuroblastoma. A case-based update.
Bianchi F, Tamburrini G, Gessi M, Frassanito P, Massimi L, Caldarelli M.
Childs Nerv Syst. 2018 May;34(5):817-823. doi: 10.1007/s00381-018-3764-3. Epub 2018 Mar 8.
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
Berlanga P, Pasqualini C, Pötschger U, Sangüesa C, Castellani MR, Cañete A, Luksch R, Elliot M, Schreier G, Kropf M, Morgenstern D, Papadakis V, Ash S, Ruud E, Brock P, Wieczorek A, Kogner P, Trahair T, Ambros P, Boterberg T, Castel V, Valteau-Couanet D, Ladenstein R.
Eur J Cancer. 2021 Feb;144:1-8. doi: 10.1016/j.ejca.2020.10.020. Epub 2020 Dec 11.
Multimodality treatment for recurrent neuroblastoma in the central nervous system.
Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL.
Pediatr Blood Cancer. 2023 Apr;70(4):e30227. doi: 10.1002/pbc.30227. Epub 2023 Jan 31.
Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group.
Wieczorek A, Stefanowicz J, Hennig M, Adamkiewicz-Drozynska E, Stypinska M, Dembowska-Baginska B, Gamrot Z, Woszczyk M, Geisler J, Szczepanski T, Skoczen S, Ussowicz M, Pogorzala M, Janczar S, Balwierz W.
BMC Cancer. 2022 Jun 25;22(1):701. doi: 10.1186/s12885-022-09776-x.
Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.
Kovalevich J, Langford D.
Methods Mol Biol. 2013;1078:9-21. doi: 10.1007/978-1-62703-640-5_2.
Primary extracranial neuroblastoma with central nervous system metastases characterization by clinicopathologic findings and neuroimaging.
Kellie SJ, Hayes FA, Bowman L, Kovnar EH, Langston J, Jenkins JJ 3rd, Pao WJ, Ducos R, Green AA.
Cancer. 1991 Nov 1;68(9):1999-2006. doi: 10.1002/1097-0142(19911101)68:9<1999::aid-cncr2820680926>3.0.co;2-0.
Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma.
Chan GC, Chan CM.
Biomolecules. 2022 Feb 24;12(3):358. doi: 10.3390/biom12030358.
Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
Kramer K, Kushner B, Heller G, Cheung NK.
Cancer. 2001 Apr 15;91(8):1510-9.
Incidence, Treatment, and Survival in Primary Central Nervous System Neuroblastoma.
Lu X, Zhang X, Deng X, Yang Z, Shen X, Sheng H, Yin B, Zhang N, Lin J.
World Neurosurg. 2020 Aug;140:e61-e72. doi: 10.1016/j.wneu.2020.04.145. Epub 2020 Apr 25.
Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7-H3 radioimmunotherapy.
Kramer K, Khan O, Haque S.
J Neurooncol. 2019 Aug;144(1):227-229. doi: 10.1007/s11060-019-03203-1. Epub 2019 Jul 16.
